Clinical evaluation of the Procleix SARS-CoV-2 assay, a sensitive, high-throughput test that runs on an automated system

Autor: Jose Maria Marimón, Tomás Pumarola, Jeffrey M. Linnen, Maria Piron, Andrés Antón, Vanessa Brès, Lourdes Palacios, Marta Bes, Lluís Puig, Silvia Sauleda, Maria Piñana, Antonio M. Minguez-Micolau, Edurne Entrena, Gloria Soria, Adrian Gurrola, Lorena Alonso-Hernandez
Přispěvatelé: Institut Català de la Salut, [Sauleda S, Bes M] Transfusion Safety Laboratory, Banc de Sang i Teixits, Servei Català de la Salut, Barcelona, Spain. [Palacios L, Alonso-Hernandez L] Progenika Biopharma, A Grifols company, Derio, Spain. [Brès V] Grifols Diagnostic Solutions Inc., San Diego, CA, USA. [Piñana M, Antón A, Pumarola T] Servei de Microbiologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Microbiology (medical)
2019-20 coronavirus outbreak
medicine.medical_specialty
Transcription-Mediated Amplification (TMA)
Investigative Techniques::Genetic Techniques::Nucleic Acid Amplification Techniques [ANALYTICAL
DIAGNOSTIC AND THERAPEUTIC TECHNIQUES
AND EQUIPMENT]

Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Otros calificadores::/diagnóstico [Otros calificadores]
técnicas de investigación::métodos epidemiológicos::diseño de la investigación epidemiológica::sensibilidad y especificidad [TÉCNICAS Y EQUIPOS ANALÍTICOS
DIAGNÓSTICOS Y TERAPÉUTICOS]

Asymptomatic
Gastroenterology
Sensitivity and Specificity
Article
Automation
COVID-19 Testing
Internal medicine
Nucleic acid test (NAT)
medicine
Other subheadings::/diagnosis [Other subheadings]
virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES]
Humans
Retrospective Studies
medicine.diagnostic_test
business.industry
SARS-CoV-2
Nucleic acid test
COVID-19
Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES]
General Medicine
High-Throughput Screening Assays
Àcids nucleics - Anàlisi
Infectious Diseases
Molecular Diagnostic Techniques
Investigative Techniques::Epidemiologic Methods::Epidemiologic Research Design::Sensitivity and Specificity [ANALYTICAL
DIAGNOSTIC AND THERAPEUTIC TECHNIQUES
AND EQUIPMENT]

COVID-19 (Malaltia) - Diagnòstic
técnicas de investigación::técnicas genéticas::técnicas de amplificación de ácidos nucleicos [TÉCNICAS Y EQUIPOS ANALÍTICOS
DIAGNÓSTICOS Y TERAPÉUTICOS]

medicine.symptom
Diagnòstic molecular
business
Clinical evaluation
Nucleic Acid Amplification Techniques
Zdroj: Scientia
Diagnostic Microbiology and Infectious Disease
Popis: COVID-19; Prueba de ácido nucleico; Amplificación mediada por transcripción COVID-19; Prova d'àcid nucleic; Amplificació mediada per la transcripció COVID-19; Nucleic acid test; Transcription-mediated amplification Testing is crucial in controlling COVID-19. The Procleix® SARS-CoV-2 assay, a transcription-mediated amplification nucleic acid test that runs on an automated system, was evaluated using inactivated virus and clinical samples. The sensitivity of the assay was assessed using heat-inactivated SARS-CoV-2 and compared to 3 other tests. Clinical validation utilized 2 sets of samples: (1) Nasal, nasopharyngeal and oropharyngeal samples (n = 963) from asymptomatic individuals, and (2) nasopharyngeal samples from symptomatic patients: 100 positive and 100 negative by RT-PCR. The Procleix assay had greater sensitivity (3-fold to 100-fold) than the comparators and had high specificity (100%) in asymptomatic subjects. In symptomatic patients, the Procleix assay detected 100% of PCR-positives and found 24 positives in the initial PCR-negatives. Eighteen of these were confirmed positive and 6 were inconclusive. These studies showed that the Procleix SARS-CoV-2 assay was a sensitive and specific tool for detecting COVID-19. This work was sponsored by Grifols Diagnostic Solutions, Inc.
Databáze: OpenAIRE